FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

427429004: Eculizumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2663031017 Eculizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2674906011 Eculizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
56791000195115 eculizumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
193241000077113 éculizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
71841000195111 Eculizumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Eculizumab (substance) Is a agent d'anticorps monoclonal false Inferred relationship Some
Eculizumab (substance) Is a Haematinic true Inferred relationship Some
Eculizumab (substance) Is a Monoclonal antibody true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Eculizumab 10mg/mL injection solution 30mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Eculizumab (substance) Inferred relationship Some
Product containing eculizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Eculizumab (substance) Inferred relationship Some 1
Product containing precisely eculizumab 300 milligram/30 milliliter conventional release solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Eculizumab (substance) Inferred relationship Some 1
Product containing precisely eculizumab 300 milligram/30 milliliter conventional release solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Eculizumab (substance) Inferred relationship Some 1
Product containing eculizumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Eculizumab (substance) Inferred relationship Some 1
Product containing only eculizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Eculizumab (substance) Inferred relationship Some 1
Product containing only eculizumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Eculizumab (substance) Inferred relationship Some 1
Product containing precisely eculizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Eculizumab (substance) Inferred relationship Some 1
Product containing precisely eculizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Eculizumab (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start